This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sabbatini, R. Articles by Silingardi, V. Search for Related Content PubMed PubMed Citation Articles by Sabbatini, R. Articles by Silingardi, V.

Detection of Circulating Tumor Cells by Reverse Transcriptase Polymerase Chain Reaction of Maspin in Patients With Breast Cancer Undergoing Conventional-Dose Chemotherapy

From the Cattedra di Oncologia Medica ed Ematologia, Dipartimento di Oncologia ed Ematologia, Università di Modena, Modena, Italy.

Address reprint requests to Massimo Federico, MD, Cattedra di Oncologia Medica, Università di Modena, Policlinico, Via del Pozzo 71, 41100 Modena, Italy; email federico{at}unimo.it

PURPOSE: To establish, in patients with breast cancer subjected to primary conventional chemotherapy and enrolled in a prospective study, the mobilizing effect of therapy on potentially neoplastic cells by means of a reverse transcriptase polymerase chain reaction (RT-PCR) assay for mRNA of maspin, a protein related to the serpin family of protease inhibitors.

PATIENTS AND METHODS: Peripheral-blood samples were collected from 30 patients with histologically proven breast cancer before and 4 and 8 days after conventional chemotherapy for three consecutive courses. A total of 216 samples were screened for the presence of maspin mRNA by RT-PCR.

RESULTS: Before therapy, all samples but one were negative. After chemotherapy, 11 patients (38%) had positive samples. No difference in the rate of positivity was observed between groups defined according to initial stage, type of chemotherapy, Ki-67–related proliferative activity, or CA 15.3 expression.

CONCLUSION: Our results confirm that RT-PCR for maspin mRNA is a sensitive assay for the study of circulating potentially neoplastic mammary cells in patients with breast cancer. Moreover, our findings indicate a marked effect of conventional-dose chemotherapy on the mobilization of these cells in breast tumors. In our series of patients, this phenomenon does not seem to be associated with other known risk factors. Finally, the data suggest, without proving, an association between the presence of circulating maspin positive cells and a higher risk of disease progression. If this association could be confirmed, then the assay could have prognostic significance. However, larger confirmatory studies are necessary.

This article has been cited by other articles:

				L. Harris, H. Fritsche, R. Mennel, L. Norton, P. Ravdin, S. Taube, M. R. Somerfield, D. F. Hayes, and R. C. Bast Jr American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer J. Clin. Oncol., November 20, 2007; 25(33): 5287 - 5312. [Abstract] [Full Text] [PDF]

				T. Nakagawa, S. R. Martinez, Y. Goto, K. Koyanagi, M. Kitago, T. Shingai, D. A. Elashoff, X. Ye, F. R. Singer, A. E. Giuliano, et al. Detection of Circulating Tumor Cells in Early-Stage Breast Cancer Metastasis to Axillary Lymph Nodes Clin. Cancer Res., July 15, 2007; 13(14): 4105 - 4110. [Abstract] [Full Text] [PDF]

				L. Mercatali, V. Valenti, D. Calistri, S. Calpona, G. Rosti, S. Folli, M. Gaudio, G. L. Frassineti, D. Amadori, and E. Flamini RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients Ann. Onc., March 1, 2006; 17(3): 424 - 428. [Abstract] [Full Text] [PDF]

				A M Gilbey, D Burnett, R E Coleman, and I Holen The detection of circulating breast cancer cells in blood J. Clin. Pathol., September 1, 2004; 57(9): 903 - 911. [Abstract] [Full Text] [PDF]

				N. Hara, T. Kasahara, T. Kawasaki, V. Bilim, K. Obara, K. Takahashi, and Y. Tomita Reverse Transcription-Polymerase Chain Reaction Detection of Prostate-specific Antigen, Prostate-specific Membrane Antigen, and Prostate Stem Cell Antigen in One Milliliter of Peripheral Blood: Value for the Staging of Prostate Cancer Clin. Cancer Res., June 1, 2002; 8(6): 1794 - 1799. [Abstract] [Full Text] [PDF]

				B. Saller, G. Feldmann, K. Haupt, M. Broecker, O. E. Janssen, M. Roggendorf, K. Mann, and M. Lu RT-PCR-Based Detection of Circulating Calcitonin-Producing Cells in Patients with Advanced Medullary Thyroid Cancer J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 292 - 296. [Abstract] [Full Text] [PDF]

				K. J. Martin, E. Graner, Y. Li, L. M. Price, B. M. Kritzman, M. V. Fournier, E. Rhei, and A. B. Pardee High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood PNAS, February 15, 2001; (2001) 41622398. [Abstract] [Full Text]

				J.-C. Goeminne, T. Guillaume, M. Federico, R. Sabbatini, M. Morselli, R. Depenni, K. Cagossi, M. Luppi, G. Torelli, and V. Silingardi Detection of Circulating Tumor by Reverse Transcriptase Polymerase Chain Reaction J. Clin. Oncol., September 17, 2000; 18(17): 3196 - 3197. [Full Text] [PDF]

				K. J. Martin, E. Graner, Y. Li, L. M. Price, B. M. Kritzman, M. V. Fournier, E. Rhei, and A. B. Pardee High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood PNAS, February 27, 2001; 98(5): 2646 - 2651. [Abstract] [Full Text] [PDF]